100 related articles for article (PubMed ID: 8174635)
1. Altered profile of transcription factor-binding activities in senescent human fibroblasts.
Dimri GP; Campisi J
Exp Cell Res; 1994 May; 212(1):132-40. PubMed ID: 8174635
[TBL] [Abstract][Full Text] [Related]
2. The helix-loop-helix protein Id-1 and a retinoblastoma protein binding mutant of SV40 T antigen synergize to reactivate DNA synthesis in senescent human fibroblasts.
Hara E; Uzman JA; Dimri GP; Nehlin JO; Testori A; Campisi J
Dev Genet; 1996; 18(2):161-72. PubMed ID: 8934878
[TBL] [Abstract][Full Text] [Related]
3. Regulation of dihydrofolate reductase gene expression and E2F components in human diploid fibroblasts during growth and senescence.
Good L; Dimri GP; Campisi J; Chen KY
J Cell Physiol; 1996 Sep; 168(3):580-8. PubMed ID: 8816912
[TBL] [Abstract][Full Text] [Related]
4. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
Marcotte R; Chen JM; Huard S; Wang E
J Cell Biochem; 2005 Dec; 96(5):1071-85. PubMed ID: 16167342
[TBL] [Abstract][Full Text] [Related]
5. The regulation of cyclin D1 expression in senescent human fibroblasts.
Fukami-Kobayashi J; Mitsui Y
Exp Cell Res; 1998 Jun; 241(2):435-44. PubMed ID: 9637785
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of p300/CBP histone acetyltransferase activates a senescence checkpoint in human melanocytes.
Bandyopadhyay D; Okan NA; Bales E; Nascimento L; Cole PA; Medrano EE
Cancer Res; 2002 Nov; 62(21):6231-9. PubMed ID: 12414652
[TBL] [Abstract][Full Text] [Related]
7. CCAAT binding transcription factor binds and regulates human COL1A1 promoter activity in human dermal fibroblasts: demonstration of increased binding in systemic sclerosis fibroblasts.
Saitta B; Gaidarova S; Cicchillitti L; Jimenez SA
Arthritis Rheum; 2000 Oct; 43(10):2219-29. PubMed ID: 11037881
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of nuclear binding activities of OXBOX-REBOX transcription factors during cellular senescence.
Lehtinen SK; Rahkila P; Helenius M; Salminen A
Biochem Biophys Res Commun; 1996 Sep; 226(2):403-6. PubMed ID: 8806647
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-kappa B.
Kleinert H; Euchenhofer C; Ihrig-Biedert I; Förstermann U
Mol Pharmacol; 1996 Jan; 49(1):15-21. PubMed ID: 8569701
[TBL] [Abstract][Full Text] [Related]
10. pRb and p107 regulate E2F activity during lens fiber cell differentiation.
Rampalli AM; Gao CY; Chauthaiwale VM; Zelenka PS
Oncogene; 1998 Jan; 16(3):399-408. PubMed ID: 9467965
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional regulation of the hepatocyte growth factor (HGF) gene by the Sp family of transcription factors.
Jiang JG; Chen Q; Bell A; Zarnegar R
Oncogene; 1997 Jun; 14(25):3039-49. PubMed ID: 9223667
[TBL] [Abstract][Full Text] [Related]
12. Nuclear factor-kappa B mediates TNF-alpha inhibitory effect on alpha 2(I) collagen (COL1A2) gene transcription in human dermal fibroblasts.
Kouba DJ; Chung KY; Nishiyama T; Vindevoghel L; Kon A; Klement JF; Uitto J; Mauviel A
J Immunol; 1999 Apr; 162(7):4226-34. PubMed ID: 10201951
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells.
Hu X; Cress WD; Zhong Q; Zuckerman KS
Biochem Biophys Res Commun; 2000 Oct; 276(3):930-9. PubMed ID: 11027571
[TBL] [Abstract][Full Text] [Related]
14. Action of transcription factors in the control of transferrin receptor expression in human brain endothelium.
Holloway K; Sade H; Romero IA; Male D
J Mol Biol; 2007 Feb; 365(5):1271-84. PubMed ID: 17125792
[TBL] [Abstract][Full Text] [Related]
15. Negative modulation of alpha1(I) procollagen gene expression in human skin fibroblasts: transcriptional inhibition by interferon-gamma.
Yuan W; Yufit T; Li L; Mori Y; Chen SJ; Varga J
J Cell Physiol; 1999 Apr; 179(1):97-108. PubMed ID: 10082137
[TBL] [Abstract][Full Text] [Related]
16. Characterization of an E2F-p130 complex formed during growth arrest.
Corbeil HB; Branton PE
Oncogene; 1997 Aug; 15(6):657-68. PubMed ID: 9264406
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of NF-kappaB signaling response to UVB light during cellular senescence.
Helenius M; Mäkeläinen L; Salminen A
Exp Cell Res; 1999 Apr; 248(1):194-202. PubMed ID: 10094826
[TBL] [Abstract][Full Text] [Related]
18. Identification of the promoter of human transcription factor Sp3 and evidence of the role of factors Sp1 and Sp3 in the expression of Sp3 protein.
Lou Z; Maher VM; McCormick JJ
Gene; 2005 May; 351():51-9. PubMed ID: 15857802
[TBL] [Abstract][Full Text] [Related]
19. Occupancy and composition of proteins bound to the AP-1 sites in the glucocorticoid receptor and c-jun promoters after glucocorticoid treatment and in different cell types.
Barrett TJ; Vedeckis WV
Recept Signal Transduct; 1996; 6(3-4):179-93. PubMed ID: 9259052
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
